These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27869427)

  • 21. Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
    Mave V; Garcia-Diaz J; Islam T; Hasbun R
    J Antimicrob Chemother; 2009 Jul; 64(1):175-80. PubMed ID: 19423543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
    Ardura MI; Mejías A; Katz KS; Revell P; McCracken GH; Sánchez PJ
    Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?
    King EA; McCoy D; Desai S; Nyirenda T; Bicking K
    J Antimicrob Chemother; 2011 Sep; 66(9):2112-8. PubMed ID: 21697178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia.
    Kvirikadze N; Suseno M; Vescio T; Kaminer L; Singh K
    Scand J Infect Dis; 2006; 38(4):290-2. PubMed ID: 16709529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing outcomes of adult oncology patients treated with linezolid versus daptomycin for bacteremia due to vancomycin-resistant Enterococcus.
    Patel K; Kabir R; Ahmad S; Allen SL
    J Oncol Pharm Pract; 2016 Apr; 22(2):212-8. PubMed ID: 25326010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical experience with daptomycin: bacteraemia and endocarditis.
    Levine DP
    J Antimicrob Chemother; 2008 Nov; 62 Suppl 3():iii35-39. PubMed ID: 18829724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Daptomycin nonsusceptible vancomycin resistant Enterococcus bloodstream infections in patients with hematological malignancies: risk factors and outcomes.
    Herc ES; Kauffman CA; Marini BL; Perissinotti AJ; Miceli MH
    Leuk Lymphoma; 2017 Dec; 58(12):2852-2858. PubMed ID: 28402152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vancomycin-resistant Enterococcus faecium (VRE) bacteremia in infective endocarditis successfully treated with combination daptomycin and tigecycline.
    Polidori M; Nuccorini A; Tascini C; Gemignani G; Iapoce R; Leonildi A; Tagliaferri E; Menichetti F
    J Chemother; 2011 Aug; 23(4):240-1. PubMed ID: 21803704
    [No Abstract]   [Full Text] [Related]  

  • 29. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).
    Mohr JF; Friedrich LV; Yankelev S; Lamp KC
    Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of daptomycin-resistant VRE: experience of a single institution.
    Kamboj M; Cohen N; Gilhuley K; Babady NE; Seo SK; Sepkowitz KA
    Infect Control Hosp Epidemiol; 2011 Apr; 32(4):391-4. PubMed ID: 21460492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative cost-effectiveness of alternative empiric antimicrobial treatment options for suspected enterococcal bacteremia.
    McComb MN; Collins CD
    Pharmacotherapy; 2014 Jun; 34(6):537-44. PubMed ID: 24390863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia.
    Balli EP; Venetis CA; Miyakis S
    Antimicrob Agents Chemother; 2014; 58(2):734-9. PubMed ID: 24247127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enterococcal Bacteremia in Children With Malignancies and Following Hematopoietic Stem Cell Transplantation: A 15-Year Single-Center Experience.
    Friedman G; Stepensky P; Abu Ahmad W; Masarwa R; Temper V; Oster Y; Amit S; Averbuch D
    Pediatr Infect Dis J; 2020 Apr; 39(4):318-324. PubMed ID: 31990889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative efficacies of daptomycin, vancomycin, and linezolid in experimental enterococcal peritonitis.
    Kajihara T; Nakamura S; Iwanaga N; Oshima K; Hirano K; Miyazaki T; Izumikawa K; Yanagihara K; Miyazaki Y; Hattori N; Kohno N; Kohno S; Mukae H
    J Infect Chemother; 2017 Jul; 23(7):498-501. PubMed ID: 28108098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival of Patients With Vancomycin-Resistant Enterococcus faecium Bacteremia Treated With Conventional or High Doses of Daptomycin or Linezolid Is Associated With the Rate of Bacterial Clearance.
    Chuang YC; Lin HY; Chen PY; Lin CY; Chen YC; Wang JT; Chang SC
    Crit Care Med; 2018 Oct; 46(10):1634-1642. PubMed ID: 29957707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/L.
    Chong PP; van Duin D; Bangdiwala A; Ivanova A; Miller WC; Weber DJ; Gilligan PH; Shea TC
    Clin Ther; 2016 Nov; 38(11):2468-2476. PubMed ID: 27771176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics and treatment outcomes of vancomycin-resistant Enterococcus faecium bacteremia.
    Ye JJ; Shie SS; Cheng CW; Yang JH; Huang PY; Wu TS; Lee MH; Huang CT
    J Microbiol Immunol Infect; 2018 Dec; 51(6):705-716. PubMed ID: 29046248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutics for Vancomycin-Resistant Enterococcal Bloodstream Infections.
    Cairns KA; Udy AA; Peel TN; Abbott IJ; Dooley MJ; Peleg AY
    Clin Microbiol Rev; 2023 Jun; 36(2):e0005922. PubMed ID: 37067406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Daptomycin therapy for vancomycin-resistant enterococcal bacteremia: a retrospective case series of 30 patients.
    Gallagher JC; Perez ME; Marino EA; LoCastro LG; Abrardo LA; MacDougall C
    Pharmacotherapy; 2009 Jul; 29(7):792-9. PubMed ID: 19558253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Outcomes of Daptomycin for Vancomycin-resistant Enterococcus Bacteremia.
    Moise PA; Sakoulas G; McKinnell JA; Lamp KC; DePestel DD; Yoon MJ; Reyes K; Zervos MJ
    Clin Ther; 2015 Jul; 37(7):1443-1453.e2. PubMed ID: 25982687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.